Skip to main content
. 2023 Jul 28;26(3):397. doi: 10.3892/ol.2023.13983

Figure 3.

Figure 3.

Kaplan-Meier analysis of the progression-free survival of patients with gastric cancer treated with immunotherapy. Stratification by (A) ALI (P=0.023) (B) MMR status (P<0.001), (C) PD-L1 expression levels (P=0.007) showed that patients with high ALI, dMMR and PD-L1 positive had higher progression-free survival times compared with those with low ALI, pMMR and PD-L1 negative. ALI, advanced lung cancer inflammation index; MMR, mismatch repair; dMMR, MMR deficient; pMMR, MMR proficient; PD-L1, programmed cell death ligand-1; CPS, combined positive score.